Evidence map›Paper›PMID 38123606›Full record

ArticleScientific reports2023

Development and implementation of the frog-in-maze game to study upper limb movement in people with Parkinson's disease.

Tuhin Virmani, Aaron S Kemp, Lakshmi Pillai, Aliyah Glover, Horace Spencer, Linda Larson-Prior

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tuhin VirmaniDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, 4301 W. Markham St., #500, Little Rock, AR, 72205, USA. TVirmani@uams.edu.
Aaron S Kemp *Department of Biomedical Informatics, University of Arkansas for Medical Sciences, 4301 W. Markham St., #500, Little Rock, AR, 72205, USA.
Lakshmi Pillai *Department of Neurology, University of Arkansas for Medical Sciences, 4301 W. Markham St., #500, Little Rock, AR, 72205, USA.
Aliyah GloverDepartment of Neurology, University of Arkansas for Medical Sciences, 4301 W. Markham St., #500, Little Rock, AR, 72205, USA.
Horace SpencerDepartment of Biostatistics, University of Arkansas for Medical Sciences, 4301 W. Markham St., #500, Little Rock, AR, 72205, USA.
Linda Larson-PriorDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, 4301 W. Markham St., #500, Little Rock, AR, 72205, USA.
University of Arkansas for Medical Sciences · US

Funding

University of Arkansas for Medical Sciences DEAP program
6 · The paper itself

Abstract

Upper-limb bradykinesia occurs early in Parkinson's disease (PD) and bradykinesia is required for diagnosis. Our goal was to develop, implement and validate a game "walking" a frog through a maze using bimanual, alternating finger-tapping movements to provide a salient, objective, and remotely monitorable method of tracking disease progression and response to therapy in PD. Twenty-five people with PD and 16 people without PD participated. Responses on 5 different mazes were quantified and compared to spatiotemporal gait parameters and standard disease metrics in these participants. Intertap interval (ITI) on maze 2 & 3, which included turns, was strongly inversely related to stride-length and stride-velocity and directly related to motor UPDRS scores. Levodopa decreased ITI, except in maze 4. PD participants with freezing of gait had longer ITI on all mazes. The responses quantified on maze 2 & 3 were related to disease severity and gait stride-length, were levodopa responsive, and were worse in people with freezing of gait, suggesting that these mazes could be used to quantify motor dysfunction in PD. Programming our frog-in-maze game onto a remotely distributable platform could provide a tool to monitor disease progression and therapeutic response in people with PD, including during clinical trials.

Indexed as

Gait Disorders, NeurologicParkinson DiseaseDisease ProgressionGaitHumansHypokinesiaLevodopaMovementUpper ExtremityLevodopa

Identifiers

PMID38123606
PMCPMC10733393
OpenAlexW4390053899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.